Chemoinformaics analysis of LUCIDENIC-ACID-D-2
| Molecular Weight | 516.631 | nRot | 5 |
| Heavy Atom Molecular Weight | 476.311 | nRig | 25 |
| Exact Molecular Weight | 516.272 | nRing | 4 |
| Solubility: LogS | -4.542 | nHRing | 0 |
| Solubility: LogP | 2.819 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 81.5177 |
| nHD | 2 | BPOL | 46.2043 |
| QED | 0.529 |
| Synth | 5.037 |
| Natural Product Likeliness | 2.96 |
| NR-PPAR-gamma | 0.875 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.906 |
| Pgp-sub | 0.005 |
| HIA | 0.038 |
| CACO-2 | -5.379 |
| MDCK | 0.0000276 |
| BBB | 0.741 |
| PPB | 0.817476 |
| VDSS | 0.274 |
| FU | 0.176743 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.219 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.824 |
| CYP2c9-inh | 0.041 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.099 |
| CYP3a4-inh | 0.04 |
| CYP3a4-sub | 0.324 |
| CL | 5.833 |
| T12 | 0.47 |
| hERG | 0.001 |
| Ames | 0.043 |
| ROA | 0.119 |
| SkinSen | 0.038 |
| Carcinogencity | 0.033 |
| EI | 0.024 |
| Respiratory | 0.785 |
| NR-Aromatase | 0.753 |
| Antiviral | Yes |
| Prediction | 0.821314 |